IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein. Read more about IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.
Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells. Read more about Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells.
A role for chromosomal instability in the development of and selection for radioresistant cell variants. Read more about A role for chromosomal instability in the development of and selection for radioresistant cell variants.
Is there a role for retinoids to treat minimal residual disease in neuroblastoma? Read more about Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells. Read more about Prostaglandin E2 and the protein kinase A pathway mediate arachidonic acid induction of c-fos in human prostate cancer cells.
Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Read more about Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
Target genes and target cells in carcinogenesis. Read more about Target genes and target cells in carcinogenesis.
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Read more about Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis.
The development of a structured rating schedule (the BAS) to assess skills in breaking bad news. Read more about The development of a structured rating schedule (the BAS) to assess skills in breaking bad news.
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Read more about Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.
